|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2235 EUR | -2.83% |
|
-6.29% | +11.97% |
| Apr. 17 | SpineGuard SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | SpineGuard SA announced that it expects to receive ?1.998 million in funding | CI |
SpineGuard SA announced that Effective, June 1st, Anne-Charlotte Millard replaces Manuel Lanfossi as Chief Financial Officer of SpineGuard. Anne-Charlotte knows the Company extensively as she held the position of Deputy Finance Director from 2009 until 2019. Since 2019, Anne-Charlotte was CFO at Biomodex a French private medtech company.
After a transition period, Manuel will leave the Company in November to pursue new endeavors.
| 1st Jan change | Capi. | |
|---|---|---|
| +11.97% | 11.32M | |
| +73.17% | 12.38B | |
| -18.74% | 7.92B | |
| +16.15% | 7.2B | |
| +4.81% | 5.84B | |
| +5.99% | 5.01B | |
| +27.07% | 4.53B | |
| -21.67% | 3.88B | |
| -40.82% | 2.23B | |
| +1.49% | 2.02B |
SPINEGUARD 
